| The first five years of the Wnt targetome A Vlad, S Röhrs, L Klein-Hitpass, O Müller Cellular signalling 20 (5), 795-802, 2008 | 173 | 2008 |
| DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control H Kretzmer, SH Bernhart, W Wang, A Haake, MA Weniger, AK Bergmann, ... Nature genetics 47 (11), 1316-1325, 2015 | 143 | 2015 |
| BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance H Quentmeier, S Eberth, J Romani, M Zaborski, HG Drexler Journal of hematology & oncology 4, 1-10, 2011 | 141 | 2011 |
| The LL-100 panel: 100 cell lines for blood cancer studies H Quentmeier, C Pommerenke, WG Dirks, S Eberth, M Koeppel, ... Scientific reports 9 (1), 8218, 2019 | 91 | 2019 |
| Chronological expression of Wnt target genes CCND1, MYC, CDKN1A, TFRC, PLF1 and Ramp3 S Röhrs, N Kutzner, A Vlad, T Grunwald, S Ziegler, O Müller Cell biology international 33 (4), 501-508, 2009 | 70 | 2009 |
| The chick chorioallantoic membrane as an in vivo xenograft model for Burkitt lymphoma M Klingenberg, J Becker, S Eberth, D Kube, J Wilting BMC cancer 14, 1-12, 2014 | 63 | 2014 |
| SOCS2: inhibitor of JAK2V617F-mediated signal transduction H Quentmeier, R Geffers, E Jost, RAF MacLeod, S Nagel, S Röhrs, ... Leukemia 22 (12), 2169-2175, 2008 | 61 | 2008 |
| The Wnt pathway destabilizes adherens junctions and promotes cell migration via β-catenin and its target gene cyclin D1 A Vlad-Fiegen, A Langerak, S Eberth, O Müller FEBS open bio 2, 26-31, 2012 | 60 | 2012 |
| SET-NUP214 fusion in acute myeloid leukemia- and T-cell acute lymphoblastic leukemia-derived cell lines H Quentmeier, B Schneider, S Röhrs, J Romani, M Zaborski, ... Journal of hematology & oncology 2, 1-5, 2009 | 59 | 2009 |
| Novel target genes of the Wnt pathway and statistical insights into Wnt target promoter regulation S Ziegler, S Röhrs, L Tickenbrock, T Möröy, L Klein‐Hitpass, IR Vetter, ... The FEBS journal 272 (7), 1600-1615, 2005 | 59 | 2005 |
| Modulation of MRP-1-mediated multidrug resistance by indomethacin analogues C Rosenbaum, S Röhrs, O Müller, H Waldmann Journal of medicinal chemistry 48 (4), 1179-1187, 2005 | 56 | 2005 |
| Solid‐Phase Synthesis of Lipidated Peptides M Lumbierres, JM Palomo, G Kragol, S Roehrs, O Müller, H Waldmann Chemistry–A European Journal 11 (24), 7405-7415, 2005 | 55 | 2005 |
| Differential requirements for the RAD51 paralogs in genome repair and maintenance in human cells EB Garcin, S Gon, MR Sullivan, GJ Brunette, AD Cian, JP Concordet, ... PLoS Genetics 15 (10), e1008355, 2019 | 49 | 2019 |
| ATP content and cell viability as indicators for cryostress across the diversity of life F Bajerski, J Stock, B Hanf, T Darienko, E Heine-Dobbernack, M Lorenz, ... Frontiers in Physiology 9, 921, 2018 | 49 | 2018 |
| Epigenetic regulation of CD44in Hodgkin and non-Hodgkin lymphoma S Eberth, B Schneider, A Rosenwald, EM Hartmann, J Romani, ... BMC cancer 10, 1-14, 2010 | 45 | 2010 |
| Aberrant lymphocyte enhancer–binding factor 1 expression is characteristic for sporadic Burkitt’s lymphoma N Walther, A Ulrich, M Vockerodt, F von Bonin, W Klapper, K Meyer, ... The American journal of pathology 182 (4), 1092-1098, 2013 | 40 | 2013 |
| CD7 in acute myeloid leukemia: correlation with loss of wild-type CEBPA, consequence of epigenetic regulation S Röhrs, M Scherr, J Romani, M Zaborski, HG Drexler, H Quentmeier Journal of hematology & oncology 3, 1-7, 2010 | 40 | 2010 |
| The NADPH oxidase inhibitor imipramine-blue in the treatment of Burkitt lymphoma M Klingenberg, J Becker, S Eberth, D Kube, J Wilting Molecular cancer therapeutics 13 (4), 833-841, 2014 | 38 | 2014 |
| Malignant hematopoietic cell lines: in vitro models for double-hit B-cell lymphomas HG Drexler, S Eberth, S Nagel, RAF MacLeod Leukemia & lymphoma 57 (5), 1015-1020, 2016 | 37 | 2016 |
| Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in Acute Myeloid Leukemia S Röhrs, WG Dirks, C Meyer, R Marschalek, M Scherr, R Slany, A Wallace, ... Molecular cancer 8, 1-11, 2009 | 37 | 2009 |
